Trospium Chloride Tablet, Film Coated
Product Images NDC 69097-912

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 69097-912). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mg (20mg)

This text describes the prescription drug Trospium Chloride, which comes in tablet form and is dispensed in a tight container. It should be stored at room temperature and pharmacists should include the package insert or fill out the prescription instructions before dispensing to the patient. The drug should be given separately to each patient, and this information is provided by a subsidiary of Cipla & SIS ann Nl Sross.*

FDA Label Image

Trospium Chloride Structural Formula (Image 01)

FDA Label Image

Figure 1 -mean (+ Sd) Concentration-time Profile For A Single 20 mg Oral Dose Of Trospium Chloride Tablets In Healthy Volunteers (Image 02)

This appears to be a graph displaying the plasma concentration (in nanograms per milliliter) at various times (in hours post-dose) for a particular substance. The x-axis displays the time points and the y-axis displays the concentration values.*

FDA Label Image

Figure 2 – Mean Change From Baseline In Urinary Frequency/24 Hours, By Visit: Study 1 (Image 03)

This appears to be a graph or chart showing the mean change with standard error between a placebo group and a group treated with trospium chloride over the course of a certain number of weeks. Additional information or context is not available.*

FDA Label Image

Figure 3 – Mean Change From Baseline In Urge Incontinence/week, By Visit: Study 1 (Image 04)

FDA Label Image

Figure 4 – Mean Change From Baseline In Urinary Frequency/24 Hours, By Visit: Study 2 (Image 05)

FDA Label Image

Figure 5 – Mean Change From Baseline In Urge Incontinence/week, By Visit: Study 2 (Image 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.